This work is licensed under a Creative Commons Attribution 4.0 International License.
V5
General Information
DRACP ID DRACP00116
Peptide Name V5
Sequence CAKAKAKAGSGAKAKAKAC
Sequence Length 19
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Membrane-targeted
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| THP-1 | Childhood acute monocytic leukemia; Acute monoblastic/monocytic leukemia | Leukemia | IC50=140 µM | CellTiter 96 AQueous One Solution assay | 1 h | 1 |
Hemolytic Activity Human erythrocytes: 50% Hemolysis=1055 µM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Cys1<--->Cys19
N-terminal Modification Acetylization
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C73H135N25O21S2
Absent amino acids DEFHILMNPQRTVWY
Common amino acids A
Mass 208443
Pl 10.8
Basic residues 6
Acidic residues 0
Hydrophobic residues 8
Net charge 6
Boman Index -1778
Hydrophobicity -29.47
Aliphatic Index 42.11
Half Life
Mammalian: 1.2 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 125
Absorbance 280nm 6.94
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 15328096
Title De novo design of potent antimicrobial peptides
Doi 10.1128/AAC.48.9.3349-3357.2004
Year 2004
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.